Alcoholic liver disease

Postgraduate Medical Journal

Volumn 76, Issue 895, 2000, Pages 280-286

  Walsh, Kevin ^a   Alexander, Graeme ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Alcohol; Cirrhosis; Liver disease

Indexed keywords

ACAMPROSATE; ALBUMIN; AMINOTRANSFERASE; BILIRUBIN; CHLORDIAZEPOXIDE; CLOMETHIAZOLE; COLLAGEN TYPE 4; CORTICOSTEROID; CYTOKINE; DISULFIRAM; FOLIC ACID; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN A; INTERLEUKIN 1BETA; INTERLEUKIN 6; LAMININ; MALOTILATE; NALMEFENE; NALTREXONE; OXANDROLONE; PREDNISOLONE; PROCOLLAGEN; PROPYLTHIOURACIL; PYRIDOXINE; RIBOFLAVIN; THALIDOMIDE; THIAMINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ALCOHOL ABSTINENCE; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ALCOHOLISM; CLINICAL FEATURE; CLINICAL TRIAL; DIET SUPPLEMENTATION; DISEASE PREDISPOSITION; DRUG INHIBITION; DRUG RECEPTOR BINDING; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER HISTOLOGY; LIVER TRANSPLANTATION; MEAN CORPUSCULAR VOLUME; META ANALYSIS; NONHUMAN; REVIEW; STEATOSIS; ULTRASOUND; VITAMIN SUPPLEMENTATION;

CYTOKINES; FEMALE; HUMANS; LIVER DISEASES, ALCOHOLIC; MALE; RISK FACTORS;

EID: 0033995069     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.76.895.280     Document Type: Review

References (45)

1. Bellentani S, Saccoccio G, Costa G, et al. Drinking habits as cofactors of risk for alcohol induced liver damage. Gut 1997;41:845-50.
2. Becker U, Deis A, Sorensen TIA, et al. Prediction of risk of liver disease by alcohol intake, sex and age: a prospective population study. Hepatology 1996;23:1025-9.
3. Kwo PY, Ramchandani VA, O'Connor S, et al. Gender differences in alcohol metabolism: relationship to liver volume and effect of adjusting for body mass. Gastroenterology 1998; 115:1552-7.
4. Tanaka K, Tokunaga S, Kono S, et al. Coffee consumtion and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol 1998;27:438-13.
5. Grant BF, Dufour MC, Harford TC. Epidemiology of alcoholic liver disease. Semin Liv Dis 1988;8:12-25.
6. Teli MR, Day CP, Burt AD, et al. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 1995;346:987-90.
7. Koskinas J, Kenna JG, Bird GL, et al. Immunoglobulin A antibody to a 200 kilodalton cytosolic acetaldehyde adduct in alcoholic hepatitis. Gastroenterology 1992;103:1060-7.
8. Xu D, Thiele GM, Beckenhauer JL, et al. Detection of circulating antibodies to malondialdehyde-acecaldehyde adducts in ethanol-fed rats. Gastroenterology 1998;115:686-92.
9. Fang C, Lindros KO, Badger TM, et al. Zonated expression of cytokines in rat liver: effect of chronic ethanol and the cytochrome P450 2E1 inhibitor, chlormethiazole. Hepatology 1998;27:1304-10.
10. Neuman MG, Shear NH, Bellentani S, et al. Role of cytokines in ethanol-induced cytotoxicity in vitro in hep G2 cells. Gastroenterology 1998;115:157-66.
11. Polavarapu R, Spitz DR, Sim JE, et al. Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. Hepatology 1998;27:1317-23.
12. Fattaccioli V, Andraud E, Gentil M, et al. Effects of ethanol administration on rat liver protease activities: relationship with oxidative stress. Hepatology 1999;29:14-20.
13. Taieb J, Mathurin P, Poynard T, et al. Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease. Lancet 1998;351:1930-1.
14. Hrubec Z, Omenn GS. Evidence of a genetic predisposition to alcoholic cirrhosis and psychosis; twin concordances for alcoholism and its biological endpoints by zygosity among male veterans. Alcohol Clin Exp Res 1981;9:306-9.
15. Grove J, Brown AS, Daly AK, et al. The RSAI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype. Pharmacogenetics 1998;8:335-42.
16. Grove J, Daly AK, Bassendine MF, et al. Association of a tumor necrosis factor polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 1997;26:143-6.
17. Day CP, Bashir R, James OF, et al. Investigation of the role of polymorphisms at the alcohol and aldehyde dehyrogenase loci in genetic predisposition to alcohol-related end-organ damage. Hepatology 1991;14:798-801.
18. Wiley TE, McCarthy M, Breidi L, et al. Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 1998;28:805-9.
19. Ludwig J, Hashimoto E, Porayko MK, et al. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997;112:882-8.
20. Grove J, Daly AK, Burt AD, et al. Heteozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease. Gut 1998;43:262-6.
21. MacDonald RA, Jones RS, Pechet GS. Folic acid deficiency and haemochromatosis. Arch Pathol 1965;80:153-60.
22. Rouault TA, Klausner RD. Iron-sulfur clusters as biosensors of oxidants and iron. Trends Biochem Sci 1996;21:174-7.
23. Ganne-Carrie N, Christidis C, Chevret S, et al. Predictive value of liver iron content for survival in 229 prospectively followed patients with cirrhosis. J Hepatol 1996;25(suppl 1):95.
24. Luca A, Carles Garcia-Pagan J, Bosch J, et al. Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis. Gastroenterology 1997;112:1284-9.
25. Maddrey WC, Biotnott JK, Bedine MS, et al. Coricosteroid therapy of alcoholic hepatitis. Gastrenterology 1978;75:193-9.
26. Menon DK, Harris M, Sargentoni J, et al. In vivo hepatic 31P magnetic resonance spectroscopy in chronic alcohol abusers. Gastroenterology 1995;108:776-88.
27. Vorobioff J, Groszmann RJ, Picabea E, et al. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study. Gastroenterology 1996;111:701-9.
28. Garbutt JC, West SL, Carey TS, et al. Pharmacological treatment of alcohol dependence. JAMA 1999;281:1318-25.
29. Chataway J, Hardman E. Thiamine in Wernicke's syndrome - how much and how long? Postgrad Med J 1995; 71:249.
30. Wrenn KD, Slovis CM. Is intravenous thiamine safe? Am J Emerg Med 1992;10:165.
31. Imperale T, McCullough A. Do corticosteroids reduce mortality from alcoholic hepatitis? Ann Intern Med 1990;113: 299-303.
32. Reynolds T, Benhamou J, Blake J. Treatment of acute alcoholic hepatitis. Gastroenterol Int 1989;2:208-16.
33. Ramond M-J, Poynard T, Rueff B, et al. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992;362:507-12.
34. Carmichael FJ, Orrego H, Saldivia V, et al. Effect of propylthiouracil on the ethanol-induced increase in liver oxygen consumption in awake rats. Hepatology 1993;18: 415-21.
35. Orrego H, Kalant H, Israel Y. Effects of short term therapy with propylthiouracil in patients with alcoholic liver disease. Gastroenterology 1979;76:105-15.
36. Halle P, Pare P, Kaptein E, et al. Double blind controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis. Gastroenterology 1982;82: 925-31.
37. Orrego H, Blake JE, Blendis LM, et al. Long-term treatment of alcoholic liver disease with propylthiouracil. N Engl J Med 1987;317:1421-7.
38. Takase S, Matsuda Y, Yasuhara M, et al. Effects of malotilate treatment on alcoholic liver disease. Alcohol 1989;6: 219-22.
39. Kim SG, Kwak JY, Lee JW, et al. Malotilate, a hepatoprotectant, suppresses CYP2E1 expression in rats. Biophys Res Commun 1994;200:1414-20.
40. Collell A, Garcia-Ruiz C, Miranda M, et al. Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor. Gastroenterology 1998; 115:1541-51.
41. Garica-Ruiz C, Morales A, Colell A, et al. Feeding S-adenosyl-L methionine attenuates both ethanol-induced depletion of mitochondrial glutathione and mitochondrial dysfunction in periportal and perivenous rat hepatocytes. Hepatology 1995;21:207-14.
42. Nanji AA, Sadrzadeh SM, Yang EK, et al. Dietary saturated fatty acids: a novel treatment for alcoholic liver disease. Gastroenterology 1995;109:547-54.
43. Mendenhall CL, Moritz TE, Roselle GA, et al. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs. Hepatology 1993;17:564-76.
44. Lieber CS, Robins SJ, Li J, et al Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology 1994;106:152-9.
45. Tang H, Boulton R, Gunson B, et al. Patterns of alcohol consumption after liver transplantation. Gut 1998;43:140-5.